Oberweis Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-609
Closed -$286K 203
2023
Q2
$286K Hold
609
0.03% 172
2023
Q1
$209K Sell
609
-30
-5% -$10.1K 0.03% 168
2022
Q4
$234K Sell
639
-29
-4% -$10.3K 0.05% 159
2022
Q3
$216K Hold
668
0.05% 165
2022
Q2
$217K Buy
+668
New +$201K 0.05% 151

Other funds holding LLY

Oberweis Asset Management's LLY Position: Q3 2023 in Review

Oberweis Asset Management sold out of Eli Lilly (LLY) in Q3 2023, closing a stake of 609 shares — an estimated $286K sold.

Oberweis Asset Management first reported a position in LLY in Q2 2022 and held it in 5 quarters. The position peaked at $286K in Q2 2023. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • Oberweis Asset Management reported no remaining Eli Lilly position as of Q3 2023 after selling out during the quarter.
  • Oberweis Asset Management sold 609 Eli Lilly shares in Q3 2023, an estimated $286K.
  • Oberweis Asset Management first reported a position in Eli Lilly in Q2 2022 and held it in 5 quarters.
  • Oberweis Asset Management's Eli Lilly position peaked at $286K in Q2 2023.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on Oberweis Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.